Physician profile
Judd E Hollander
NPI 1427098425
$43,561.79
in general payments reported to CMS, 2019-2025
6 companies · $2,561 in 2025
The $2,561 reported for 2025 was more than what 97% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,550 · 2021: $5,945 · 2022: $18K · 2023: $6,155 · 2024: $1,717 · 2025: $2,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,400 · Travel and Lodging: $5,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,400.00 |
| Travel and Lodging | $5,033.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $16,050.00 | 2022-2023 | |
| Teladoc Health, INC. | $11,342.11 | 2022-2025 | |
| Roche Diagnostics Corporation | $9,549.55 | 2019 | |
| Astrazeneca Ab | $4,345.13 | 2021 | |
| Janssen Scientific Affairs, LLC | $1,600.00 | 2021 | |
| Abbott Laboratories | $675.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judd Hollander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.